Castrate Resistance Prostate Cancer
2 clinical trials · Condition
◉ Watch Castrate Resistance Prostate Cancer
| Record | Firm | Date |
|---|---|---|
| Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer (NCT06927635) | University Health Network, Toronto | 2025-07-08 |
| Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer (NCT04113005) | Sunnybrook Health Sciences Centre | 2019-10-01 |
Track Castrate Resistance Prostate Cancer automatically
Every clearance here is in the API, with alerts when new ones post.